Emergent BioSolutions Inc. is a publicly traded enterprise listed on the New York Stock Exchange under the ticker symbol EBS, meaning it is collectively owned by public and institutional shareholders rather than a single private entity. Institutional asset management firms, mutual funds, and retail investors hold the vast majority of its common stock shares, alongside equity ownership retained by corporate officers and executive management team members.